Opioid anesthetics

Subsys

Approved 4 Jan 2012Under the tongueSpray

The FDA lists this product in 7 strengths and forms.

Official labelAsk Osler about it

Composition

Active ingredients: FENTANYL 1.6MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

FENTANYL 1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SprayNDA202788-006 · Discontinued
FENTANYL 0.6MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SprayNDA202788-004 · Discontinued
FENTANYL 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SprayNDA202788-002 · Discontinued
FENTANYL 1.6MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SprayThis page
FENTANYL 0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SprayNDA202788-005 · Discontinued
FENTANYL 0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SprayNDA202788-003 · Discontinued
FENTANYL 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Spray

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

NDA202788-001 · Discontinued

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application NDA202788.

Open Drugs@FDA

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.